Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease

European Respiratory Review : an Official Journal of the European Respiratory Society
Melissa CaronRussell Steele

Abstract

Interstitial lung disease (ILD) is the leading cause of morbidity and mortality in systemic sclerosis (SSc). We performed a systematic review to characterise the use and validation of pulmonary function tests (PFTs) as surrogate markers for systemic sclerosis-associated interstitial lung disease (SSc-ILD) progression.Five electronic databases were searched to identify all relevant studies. Included studies either used at least one PFT measure as a longitudinal outcome for SSc-ILD progression (i.e. outcome studies) and/or reported at least one classical measure of validity for the PFTs in SSc-ILD (i.e. validation studies).This systematic review included 169 outcome studies and 50 validation studies. Diffusing capacity of the lung for carbon monoxide (DLCO) was cumulatively the most commonly used outcome until 2010 when it was surpassed by forced vital capacity (FVC). FVC (% predicted) was the primary endpoint in 70.4% of studies, compared to 11.3% for % predicted DLCO Only five studies specifically aimed to validate the PFTs: two concluded that DLCO was the best measure of SSc-ILD extent, while the others did not favour any PFT. These studies also showed respectable validity measures for total lung capacity (TLC).Despite the cur...Continue Reading

References

Sep 1, 1991·The American Review of Respiratory Disease·N K HarrisonM Turner-Warwick
Jul 1, 1991·Postgraduate Medical Journal·M J AbramsonS Hall
May 1, 1990·The American Journal of Medicine·R M SilverS I Schabel
Jan 1, 1989·Respiration; International Review of Thoracic Diseases·C J ZarafonetisW Y Yuan
May 1, 1988·Seminars in Arthritis and Rheumatism·D S McCarthyL Martin
Aug 1, 1985·Arthritis and Rheumatism·V D SteenT A Medsger
Mar 1, 1984·Chest·G KönigG Fruhmann
Sep 1, 1982·The American Journal of Medicine·P D SchneiderF M Wigley
Sep 1, 1994·Arthritis and Rheumatism·V D SteenT A Medsger
May 1, 1994·British Journal of Rheumatology·Z DujićD Andjelinović
Oct 1, 1993·The American Review of Respiratory Disease·A U WellsR M du Bois
Dec 1, 1993·AJR. American Journal of Roentgenology·A U WellsD M Hansell
Jan 1, 1995·Respiration; International Review of Thoracic Diseases·J BehrG Fruhmann
Aug 1, 1996·American Journal of Respiratory and Critical Care Medicine·J BehrG Fruhmann
Aug 15, 2001·Arthritis and Rheumatism·I MarieH Courtois
Jun 19, 2002·American Journal of Respiratory and Critical Care Medicine·Demosthenes BourosRoland M du Bois
Nov 3, 2005·The European Respiratory Journal·R PellegrinoJ Wanger
Jun 23, 2006·The New England Journal of Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Jul 29, 2006·Arthritis and Rheumatism·Sotiris C PlastirasGeorge E Tzelepis
Sep 7, 2006·Journal of Computer Assisted Tomography·Ilaria OrlandiMario Mascalchi
May 9, 2007·Annals of the Rheumatic Diseases·Philip J ClementsUNKNOWN Scleroderma Lung Study Group
Aug 25, 2007·American Journal of Respiratory and Critical Care Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Sep 29, 2007·American Journal of Respiratory and Critical Care Medicine·Charlie StrangeUNKNOWN Scleroderma Lung Study Research Group

❮ Previous
Next ❯

Citations

May 23, 2019·Multidisciplinary Respiratory Medicine·Nicola CiancioGianluca Sambataro
Sep 20, 2019·Rheumatology·Sabrina HoaUNKNOWN Canadian Scleroderma Research Group
Feb 23, 2020·The European Respiratory Journal·Oliver DistlerToby M Maher
Dec 1, 2019·BMC Pulmonary Medicine·Ralf EwertGabor Kovacs
Jun 18, 2019·Journal of X-ray Science and Technology·Nan YinLu Bai
Sep 7, 2018·Annals of the American Thoracic Society·Sabina A GulerChristopher J Ryerson
Aug 1, 2019·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·F M AndradeA J Lopes
Oct 4, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Bridget F Collins, Ganesh Raghu
Mar 7, 2021·Pharmaceuticals·Barbara RuaroCosimo Bruni
Mar 25, 2021·Current Allergy and Asthma Reports·Sendhilnathan Ramalingam, Ankoor Shah
May 27, 2021·Scientific Reports·Julien GuiotRenaud Louis
Jun 16, 2021·Journal of Breath Research·Yu ZhengXueling Wu
Jun 26, 2021·Clinical Imaging·Kathleen M CapaccioneMary M Salvatore
Nov 30, 2021·International Journal of Rheumatic Diseases·Flavia V CastelinoVirginia Steen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.